Ronald K. Yamamoto
Fundador en Oxular Ltd. .
Cargos activos de Ronald K. Yamamoto
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Oxular Ltd.
Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Director/Miembro de la Junta | 01/01/2014 | - |
Director Técnico/Científico/I+D | 01/01/2014 | - | |
Fundador | 01/01/2014 | - |
Historial de carrera de Ronald K. Yamamoto
Antiguos cargos conocidos de Ronald K. Yamamoto.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BIOCEPT, INC. | Director/Miembro de la Junta | - | - |
Halscion, Inc.
Halscion, Inc. Medical SpecialtiesHealth Technology Halscion, Inc. developed technologies and biomaterial to treat dermatological conditions. It offered a device for the reduction in the appearance of scars resulting from acute surgical wounds. The company was founded by Charles E. Larsen, Thomas D. Weldon, and Gerard van Hamel Platerink in 2005 and was headquartered in Suwanee, GA. | Director/Miembro de la Junta | - | - |
Vitaphore Corp. | Director Técnico/Científico/I+D | 01/03/2013 | - |
Fundador | 01/03/2013 | - | |
POINT Biomedical Corp.
POINT Biomedical Corp. Pharmaceuticals: MajorHealth Technology POINT Biomedical Corp. develops biomedical-imaging products. It manufactures products for diagnostic, molecular imaging, and drug delivery applications based on biSphere technology. The company was founded in 1996 and is headquartered in San Carlos, CA. | Director Técnico/Científico/I+D | - | - |
Presidente | - | - | |
iScience Interventional Corp.
iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Director/Miembro de la Junta | - | - |
Director Técnico/Científico/I+D | - | - |
Formación de Ronald K. Yamamoto.
California Institute of Technology | Undergraduate Degree |
Clemson University | Graduate Degree |
University of Southern California | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 9 |
Reino Unido | 2 |
Operativa
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 4 |
Graduate Degree | 2 |
Sectorial
Health Technology | 5 |
Consumer Services | 4 |
Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BIOCEPT, INC. | Health Technology |
Empresas privadas | 5 |
---|---|
iScience Interventional Corp.
iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Health Services |
Vitaphore Corp. | |
POINT Biomedical Corp.
POINT Biomedical Corp. Pharmaceuticals: MajorHealth Technology POINT Biomedical Corp. develops biomedical-imaging products. It manufactures products for diagnostic, molecular imaging, and drug delivery applications based on biSphere technology. The company was founded in 1996 and is headquartered in San Carlos, CA. | Health Technology |
Halscion, Inc.
Halscion, Inc. Medical SpecialtiesHealth Technology Halscion, Inc. developed technologies and biomaterial to treat dermatological conditions. It offered a device for the reduction in the appearance of scars resulting from acute surgical wounds. The company was founded by Charles E. Larsen, Thomas D. Weldon, and Gerard van Hamel Platerink in 2005 and was headquartered in Suwanee, GA. | Health Technology |
Oxular Ltd.
Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Ronald K. Yamamoto
- Experiencia